Homoharringtonine Sodium Chloride Injection
Indication
It is suitable for the induction remission and continued treatment stages of various types of acute non-lymphocytic leukemia, especially for acute promyelocytic leukemia, acute monocytic leukemia, and acute myeloid leukemia. It also has certain effects on myelodysplastic syndrome (MDS), chronic myeloid leukemia, and polycythemia vera.
Packaging Specification
100ml: Homoharringtonine 2mg and sodium chloride 0.9g
Manufacturer
Shanxi Zhendong Taisheng Pharmaceutical Co., Ltd.
-
Founded in:
1993-07-05 -
Address:
The First Pharmaceutical Park, Economic and Technological Development Zone, Datong City, Shanxi Province -
Tax NO.:
91140200602165291J -
Registered Funds:
395 million yuan -
Website:
-
Email: